Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer.

JS, Berek; PT, Taylor; A, Gordon; MJ, Cunningham; N, Finkler; J Jr, Orr; S, Rivkin; BC, Schultes; TL, Whiteside; CF, Nicodemus

doi:10.1200/jco.2004.09.016

Public

Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer.

Shared by NobleBlocks on Sep 1, 2004 • 12:00 AM UTC

Authors:

Berek JS

Taylor PT

Gordon A

Abstract

<h4>Purpose</h4>To assess oregovomab as consolidation treatment of advanced ovarian cancer and refine the immunotherapeutic strategy for subsequent study.<h4>Patients and methods</h4>Patients with stage III/IV ovarian cancer who had a complete clinical response to primary treatment were randomly ass...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!